Skip to content
Lower risk Drug recall · FDA · Published April 13, 2018

Lyne Laboratories Recalls Fluocinolone Scalp Oil Due to Subpotent Drug Risk

Lyne Laboratories recalls 0.01% Fluocinolone Acetonide Topical Oil (Scalp Oil) 4 fl.oz. Rx only due to subpotent drug levels. This may not provide intended treatment for scalp conditions.

🇺🇸 FDA recall #D-0713-2018DrugLyne Laboratories ›
Take action

Contact the company

Recalling firmLyne Laboratories, Inc.10 Burke Dr · Brockton, MA 02301-5505
✎ GovInfoNow plain-language explainer

What happened, in plain English

Lyne Laboratories is recalling a 4 fl.oz. scalp oil medication that may not contain enough active ingredient to treat scalp conditions. This subpotent drug risk means the product might not work as intended for people using it under a doctor's prescription. Read more at govinfonow.com/recall/40612-lyne-laboratories-recalls-fluocinolone-scalp-oil-due-to-subpotent-drug.

Source Summary by GovInfoNow · govinfonow.com/recall/40612-lyne-laboratories-recalls-fluocinolone-scalp-oil-due-to-subpotent-drug · Updated October 7, 2026 · FDA enforcement record: FDA #D-0713-2018

Cite this page

“Lyne Laboratories Recalls Fluocinolone Scalp Oil Due to Subpotent Drug Risk.” GovInfoNow, updated October 7, 2026. https://govinfonow.com/recall/40612-lyne-laboratories-recalls-fluocinolone-scalp-oil-due-to-subpotent-drug. Based on FDA recall #D-0713-2018 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0713-2018%22&limit=1).

Why it’s dangerous

The product contains less active drug than intended, so it may not effectively treat scalp conditions. This subpotent drug risk means the medication might not work as prescribed by a doctor.

Who’s affected

People with a prescription for this scalp oil medication from Lyne Laboratories. Those with scalp conditions requiring treatment are most at risk.

How to tell if you have this one

Check for the product name 'Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx Only'. Look for lot numbers FR1601 or FR1602 and expiration date 05/2018.

  • Brand
    Lyne Laboratories
  • Product
    Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx Only, Manufactured by: Lyne Laboratories
  • Category
    Drug
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    to be entered
Recall numberProduct, codes & lotsQuantityNDC
D-0711-2018Fluocinolone Acetonide Topical Oil, 0.01% (Body Oil) 118.28 mL (4 fl. oz.) Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-331-04, UPC 364980331043; Lot #: FR1603, FR1604A, Exp. 05/201812572 units64980-331-04, 3649803310
D-0712-2018Fluocinolone Acetonide Topical Oil, 0.01% (Ear Drops) 20 mL, Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-329-20, UPC 364980329200; Lot#: FR1604B, FR1604C, FR 1604D, Exp. 06/201817939 units64980-329-20, 3649803292
D-0713-2018Fluocinolone Acetonide Topical Oil, 0.01% (Scalp Oil) 118.28 mL (4 fl.oz.) Rx Only, Manufactured by: Lyne Laboratories, Inc. Brockton, MA 02307 Manufactured for: Rising Pharmaceuticals, Inc. Allendale, NJ 07401, NDC 64980-330-04, UPC 364980330046; Lot #: FR1601, FR1602, Exp. 05/201823453 units64980-330-04, 3649803300
Based on the official FDA remedy

What to do — step by step

  1. Check Product Details

    Look for lot numbers FR1601 or FR1602 and expiration date 05/2018 on the product label.

How this recall unfolded

Recall timeline

FDA terminated this recall 13 months after the firm started it.

1. Firm started the recall: Apr 13, 201812. Published in FDA’s Enforcement Report: May 2, 201823. FDA classified it Class II: May 4, 201834. FDA terminated the recall: May 16, 2019420182019
  1. Firm started the recall
  2. Published in FDA’s Enforcement Report
  3. FDA classified it Class II
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0713-2018 (April 13, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0713-2018 to see it in context.
  • Plain-language summary written by qwen3:4b on October 7, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA